Anonymous
Guest
Anonymous
Guest
It was so nice to not see you having conversations with yourself all day here today. Parole hearing? Electric shock therapy?
r*****, there names are spelled "Frohlich" and "Ranieri".
The worst "cancer" of all are your sickening posts on this board.
What gripe do you have against Dr. Frohlich? You should be real pleased he is with the company as he is a real asset (unless of course you are an idiot short).
Dr. Frohlich serves as our executive vice president of research and development and chief medical officer. Dr. Frohlich previously served as our vice president of clinical affairs and prior to that served as our senior medical director. Prior to joining Dendreon, Dr. Frohlich was vice president and medical director at Xcyte Therapies, a biotechnology company. Prior to that was an assistant professor in the Division of Hematology/Oncology at the University of California, San Francisco, where he specialized in urologic oncology and was active in laboratory, translational and clinical research. Dr. Frohlich did his post doctoral training in oncology at the University of California, San Francisco. He received his B.S. from Yale University in electrical engineering and economics and his M.D. from Harvard Medical School.
You are a freakin idiot.
r*****, there names are spelled "Frohlich" and "Ranieri".
The worst "cancer" of all are your sickening posts on this board.
What gripe do you have against Dr. Frohlich? You should be real pleased he is with the company as he is a real asset (unless of course you are an idiot short).
Dr. Frohlich serves as our executive vice president of research and development and chief medical officer. Dr. Frohlich previously served as our vice president of clinical affairs and prior to that served as our senior medical director. Prior to joining Dendreon, Dr. Frohlich was vice president and medical director at Xcyte Therapies, a biotechnology company. Prior to that was an assistant professor in the Division of Hematology/Oncology at the University of California, San Francisco, where he specialized in urologic oncology and was active in laboratory, translational and clinical research. Dr. Frohlich did his post doctoral training in oncology at the University of California, San Francisco. He received his B.S. from Yale University in electrical engineering and economics and his M.D. from Harvard Medical School.
You are a freakin idiot.